How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Role of Nonpharmaceutical Interventions during 1918–1920 Influenza Pandemic, Alaska, USA – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Peromyscus spp. Deer Mice as Rodent Model of Acute Leptospirosis – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Correction: Vol. 30, No. 8 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Promising Effects of Duck Vaccination against Highly Pathogenic Avian Influenza, France 2023–2024 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Emergence of Flucytosine-Resistant Candida tropicalis Clade, the Netherlands – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Correction: Vol. 30, No. 6 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Spatiotemporal Distribution and Clinical Characteristics of Zoonotic Tuberculosis, Spain, 2018–2022 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Transmission Dynamics and Parameters for Pertussis during School-Based Outbreak, South Korea, 2024 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Communicable disease threats report, 31 May – 5 June 2025, week 23

Early Release – Persistence of SARS-CoV-2 Alpha Variant in White-Tailed Deer, Ohio, USA – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us